Management of women who test positive for high-risk types of human papillomavirus: the HART study
Jack Cuzick(Queen Mary University of London), Peter Sasieni(Queen Mary University of London), Henry C Kitchener(University of Manchester), Mina Desai(The Christie Hospital), G. Hulman(Nottingham City Hospital), Euphemia McGoogan(Edinburgh Royal Infirmary), David Luesley(Birmingham Women's Hospital), Anne Szarewski(Cancer Research UK), C Pickles(Kings Mill Hospital), Linda Ho(Queen Mary University of London), Clive Gie(Kings Mill Hospital), Robert P. Edwards(Cancer Research UK Technology), George Terry(Cancer Research UK Technology), Usha Menon(University of South Florida), Heather Cubie(Edinburgh Royal Infirmary), Claire Brooks(Cancer Research UK Technology), Ian Jacobs(Children's Hospital of Philadelphia)
Cited by 505
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
|New England Journal of Medicine|2019|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k